R.A. De Weger

805 total citations
40 papers, 659 citations indexed

About

R.A. De Weger is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R.A. De Weger has authored 40 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 13 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R.A. De Weger's work include Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (6 papers). R.A. De Weger is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (6 papers). R.A. De Weger collaborates with scholars based in Netherlands, Slovakia and United States. R.A. De Weger's co-authors include L. H. P. M. Rademakers, Marcel G.J. Tilanus, Willem Den Otter, Jan G. van den Tweel, G C de Gast, Hub F. J. Dullens, Frank P. van de Wijngaert, Henk‐Jan Schuurman, L Kater and Peter W. de Graaf and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Journal of Clinical Microbiology.

In The Last Decade

R.A. De Weger

40 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.A. De Weger Netherlands 15 239 232 139 111 107 40 659
H Yamada Japan 16 96 0.4× 277 1.2× 167 1.2× 65 0.6× 61 0.6× 26 737
S Ohzeki Japan 9 167 0.7× 396 1.7× 169 1.2× 58 0.5× 56 0.5× 9 633
C A Penning United States 13 250 1.0× 226 1.0× 436 3.1× 69 0.6× 163 1.5× 17 918
Arnaud Dupuy d’Angeac France 11 169 0.7× 410 1.8× 251 1.8× 105 0.9× 85 0.8× 28 886
Heiner Frost Switzerland 15 145 0.6× 602 2.6× 253 1.8× 219 2.0× 50 0.5× 29 972
K Iida Japan 10 86 0.4× 270 1.2× 202 1.5× 59 0.5× 69 0.6× 17 724
G M Butchko United States 14 174 0.7× 259 1.1× 103 0.7× 411 3.7× 191 1.8× 19 822
Esther S. Trueblood United States 12 352 1.5× 526 2.3× 231 1.7× 136 1.2× 64 0.6× 24 1.0k
Frank J. Ward United Kingdom 15 176 0.7× 474 2.0× 148 1.1× 111 1.0× 54 0.5× 34 782
S. Craig Stocks United Kingdom 12 106 0.4× 261 1.1× 226 1.6× 125 1.1× 43 0.4× 14 569

Countries citing papers authored by R.A. De Weger

Since Specialization
Citations

This map shows the geographic impact of R.A. De Weger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.A. De Weger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.A. De Weger more than expected).

Fields of papers citing papers by R.A. De Weger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.A. De Weger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.A. De Weger. The network helps show where R.A. De Weger may publish in the future.

Co-authorship network of co-authors of R.A. De Weger

This figure shows the co-authorship network connecting the top 25 collaborators of R.A. De Weger. A scholar is included among the top collaborators of R.A. De Weger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.A. De Weger. R.A. De Weger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wichen, D.F. van, et al.. (1998). Intracardiac Dendritic Cells and Expression of Co-Stimulatory Molecules After Heart Transplantation. Transplantation Proceedings. 30(3). 913–915. 1 indexed citations
2.
Rademakers, L. H. P. M., et al.. (1997). Fibronectin Distribution in Human Bone Marrow Stroma: Matrix Assembly and Tumor Cell Adhesion via α5β1 Integrin. Experimental Cell Research. 230(1). 111–120. 50 indexed citations
3.
Klein, Sigrid, et al.. (1997). Release of Cytokines and Soluble Cell Surface Molecules by PBMC after Activation with the Bispecific Antibody CD3 × CD19. Scandinavian Journal of Immunology. 46(5). 452–458. 16 indexed citations
4.
5.
Hoffen, Els van, F.H.J. Gmelig-Meyling, Howard Hu, et al.. (1997). Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation.. PubMed. 16(2). 216–21. 4 indexed citations
6.
Bruggink, Annette H., Murray Korc, Michael S. Kobrin, et al.. (1996). Overexpression of transforming growth factor-α and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. Carcinogenesis. 17(4). 779–785. 12 indexed citations
7.
Wichen, D.F. van, et al.. (1996). Expression of Two Interleukin 4 mRNA Isoforms in B Lymphoid Cells. Cellular Immunology. 167(2). 259–268. 18 indexed citations
8.
Gast, G C de, Anja A. van Houten, Inez-Anne Haagen, et al.. (1995). Clinical Experience with CD3 X CD19 Bispecific Antibodies in Patients with B Cell Malignancies. Journal of Hematotherapy. 4(5). 433–437. 55 indexed citations
9.
Prooijen, H. C. van, et al.. (1995). Prevention of donor‐specific T‐cell unresponsiveness after buffy‐coat‐depleted blood transfusion. British Journal of Haematology. 91(1). 219–223. 12 indexed citations
10.
11.
Schuurman, Henk‐Jan, D.F. van Wichen, L. H. P. M. Rademakers, et al.. (1995). Follicular Dendritic Cells and Infection by Human Immunodeficiency Virus Type 1—A Crucial Target Cell and Virus Reservoir. Current topics in microbiology and immunology. 201. 161–188. 6 indexed citations
12.
Schuurman, H.J., et al.. (1993). Thoughts on the thymus and the T-lymphocyte repertoire. Relevance to the tolerance of the immune response.. PubMed. 43(1-2). 38–54. 5 indexed citations
13.
Vos, J. H., J. S. van der Linde‐Sipman, R.A. De Weger, et al.. (1992). Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study. Research in Veterinary Science. 53(2). 198–204. 24 indexed citations
14.
Roholl, Paul, et al.. (1991). Expression of growth factors and their receptors on human sarcomas. Immunohistochemical detection of platelet-derived growth factor, epidermal growth factor and their receptors. TNO Repository. 4(2). 83–88. 7 indexed citations
15.
16.
Terpstra, G. K., et al.. (1987). Changes in alveolar macrophage enzyme content and activity in smokers and patients with chronic obstructive lung disease.. PubMed. 7(4). 273–7. 2 indexed citations
17.
Pels, Elisabeth, R.A. De Weger, & Willem Den Otter. (1984). Lymphocyte-Induced Macrophage Cytotoxicity. International Archives of Allergy and Immunology. 74(2). 140–146. 8 indexed citations
18.
Pels, Elisabeth, R.A. De Weger, & Willem Den Otter. (1984). Lymphocyte Induced Macrophage Cytotoxicity: Characterization of the Macrophage Cytotoxicity-Inducing Lymphocyte. Immunobiology. 166(1). 84–95. 14 indexed citations
19.
Dullens, Hub F. J. & R.A. De Weger. (1980). Oncostatic-antibody complexes in chemotherapy. Cancer Chemotherapy and Pharmacology. 4(1). 29–32. 4 indexed citations
20.
Dullens, Hub F. J., et al.. (1979). Comparison of various forms of therapy in two different mouse tumor systems.. PubMed. 63(1). 99–109. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Yamada Breakdown of academic impact, for papers by S Ohzeki Breakdown of academic impact, for papers by C A Penning Breakdown of academic impact, for papers by Arnaud Dupuy d’Angeac Breakdown of academic impact, for papers by Heiner Frost Breakdown of academic impact, for papers by K Iida Breakdown of academic impact, for papers by G M Butchko Breakdown of academic impact, for papers by Esther S. Trueblood Breakdown of academic impact, for papers by Frank J. Ward Breakdown of academic impact, for papers by S. Craig Stocks
Rankless by CCL
2026